Latest Private Placement News

AdAlta has secured A$2.5 million in a strategic placement to push its lead CAR-T therapy BZDS1901 through critical US FDA regulatory steps and establish Australian manufacturing, building on promising clinical responses in advanced mesothelioma.

Hot Chili Limited secured A$40 million in a private placement to fast-track development of its Costa Fuego copper-gold project in Chile, buoyed by significant high-grade drill results extending the La Verde discovery footprint.

AdAlta has launched its East-to-West cellular immunotherapy strategy through a co-development deal for CAR-T therapy BZDS1901, showing promising complete tumour clearance in mesothelioma patients and transferring manufacturing to Australia to boost scalability.

Enegex Limited has defined a large, shallow gold system at its Kalama Bave prospect in Côte d’Ivoire, with high-grade intercepts from aircore drilling and a new gold zone identified nearby. A $10.2 million capital raise supports ongoing exploration including a planned 3,000m RC program at Gogo.

SportsHero’s HeroPlay platform hit a milestone with over 3,000 daily subscriber sign-ups in Indonesia during 3QFY26, while ARPU more than doubled amid heavy marketing support. The company secured $4.3 million in new capital and is gearing up for an expanded regional rollout and new campaigns ahead of the FIFA World Cup.

Ragusa Minerals has taken a major step in its US expansion by acquiring a controlling stake in Pegasus Tel Inc. and its Purple Pansy Manganese-Gold Project, backed by high-grade assay results and fresh capital.

Anteris Technologies has gained U.S. Medicare reimbursement eligibility for its pivotal PARADIGM Trial, clearing a key hurdle for clinical site activation and accelerating its transcatheter heart valve study.

Horizon Gold has confirmed new high-grade gold shoots at its Kingfisher prospect, underpinning resource growth potential, while progressing a major $30 million capital raise and leadership transition.

Temas Resources has closed a CAD 1.5 million flow-through share placement with Maple Leaf Critical Minerals Fund, reinforcing funding for its Quebec titanium projects and proprietary Regenerative Chloride Leach technology commercialisation.

Firebrick Pharma secured regulatory approval for Nasodine Nasal Spray in Indonesia and launched Nasodine Throat Spray in Singapore and Fiji, while raising $1.5 million to fuel growth. The company aims to quadruple its product and market footprint within three years.

Mineral Resources has priced a US$1.3 billion senior unsecured notes offering to refinance higher-cost debt, reduce annual finance expenses by $48 million, and extend its weighted average debt maturity from 3.1 to 5 years.

Temas Resources is tapping the Canadian market with a $1.5 million flow-through share placement aimed at advancing its titanium projects in Quebec. The raise supports exploration expenses tied to its proprietary processing technology and resource development.